← Back to Clinical Trials
Recruiting NCT06704048

NCT06704048 Healthrelated Quality of Life and Experiences of a Heart Rehabilitation Programme After Care for Infective Endocarditis.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06704048
Status Recruiting
Phase —
Sponsor Region Halland
Condition Infective Endocarditis
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2024-08-22
Primary Completion 2028-08

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 90 Years
Study Type INTERVENTIONAL
Interventions
Cardiac rehabilitation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2024-08-22 with a primary completion date of 2028-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

How does health develop after Infective endocarditis (IE)? Can the health of patients with IE be improved by participation in the physical exercise training within cardiac rehabilitation program? Participants will: * Answer digitally surveys on the perceived health for 4 times during 1 year * Participate in interviews on patient's experiences of health and rehabilitation 1 time before and 2 times after the training program during I year. * Be physically evaluated by a physiotherapist before and after the progam of physical exercise training within cardiac rehabilitation. * Do individual exercises in a group led by a physiotherapist 2 times weekly during 12 weeks.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of infective endocarditis (IE) based on Dukes ISCVID criteria and discharged after treatment for IE from the Department of Infectious Diseases, Hospital of Halmstad, Region Halland, Sweden. Exclusion Criteria: * Not able to do a bicycle ergometer test or training.

Contact & Investigator

Central Contact

Helena Lindberg, MD

✉ helena.lindberg@regionhalland.se

📞 +4635131000

Principal Investigator

Ingrid Larsson, PhD,Prof

STUDY DIRECTOR

Department of Health and Nursing, School of Health and Welfare, Halmstad, Sweden

Frequently Asked Questions

Who can join the NCT06704048 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Infective Endocarditis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06704048 currently recruiting?

Yes, NCT06704048 is actively recruiting participants. Contact the research team at helena.lindberg@regionhalland.se for enrollment information.

Where is the NCT06704048 trial being conducted?

This trial is being conducted at Halmstad, Sweden.

Who is sponsoring the NCT06704048 clinical trial?

NCT06704048 is sponsored by Region Halland. The principal investigator is Ingrid Larsson, PhD,Prof at Department of Health and Nursing, School of Health and Welfare, Halmstad, Sweden. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology